CONCEPTION RATES AFTER CANCER USING CRYOPRESERVED EMBRYOS
Hazel B. Nichols(University of North Carolina at Chapel Hill), Barbara Luke(Michigan State University), Allison M. Deal(Memorial Sloan Kettering Cancer Center), Steven D. Spandorfer(Cornell University), Sara Mitra(University of North Carolina at Chapel Hill), Valerie L. Baker(Johns Hopkins University), Carey K. Anders(Duke University), Jianwen Cai(University of North Carolina at Chapel Hill), Chelsea Anderson(University of North Carolina at Chapel Hill)
Cited by 1
Related Papers
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
|Journal of Clinical Oncology|2015|2.6k
Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment
|JAMA|2017|2.3k
Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer
|New England Journal of Medicine|2019|1.3k
Brain metastases
|Nature Reviews Disease Primers|2019|1.1k
Young Age at Diagnosis Correlates With Worse Prognosis and Defines a Subset of Breast Cancers With Shared Patterns of Gene Expression
|Journal of Clinical Oncology|2008|917